Drug Trial Radar · NCT01591785
Treatment of Staphylococcus Aureus Colonization in Hand Eczema
Last checked: Nov 20, 2026Latest source record: Dec 3, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
60
Actual
Start
Jan 2012
Primary completion
Aug 2012
Study completion Aug 2012
Sponsor
- Lead sponsor
- Gary GoldenbergAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 4, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Atopic dermatitis is a chronic disease characterized by itching and eczematous lesions. In adults, eczema commonly localizes to the hands or feet. Several studies have implicated bacterial contamination, especially with Staphylococcus aureus (S. aureus), to be a factor in atopic dermatitis, as infection with this bacteria correlates with disease severity. No trial to date has investigated how to treat S. aureus infection in adults with hand or hand/foot dermatitis. Using retapamulin ointment in the nose and on the hands or hands/feet, the investigators expect to have a significant clearance rate of s. aureus infection. The investigators believe that treating the bacterial infection along with treating the condition with a topical corticosteroid will significantly decrease the severity of hand/foot dermatitis in our study population.
Conditions
- Hand Eczema
- Foot Eczema
Interventions
Retapamulin 1% ointmentDrug
Retapamulin 1% ointment for 5 days AND clobetasol propionate foam for 14 days
PlaceboDrug
Placebo ointment for 5 days AND clobetasol propionate foam for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With PGA of 0 or 1Time frame: Day 15
- Number of Participants With PGA of 0 or 1Time frame: Day 28
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mount Sinai School of Medicine
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.